Results 101 to 110 of about 12,752 (178)
Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes [PDF]
, 1995 Des formes épimastigotes du parasite #Trypanosoma cruzi$ ont été rendues résistantes au benznidazole en utilisant, in vitro, une pression médicamenteuse continue.
Barnabé, Christian +2 more
core
The genetics and genomics of Trypanosoma cruzi [PDF]
, 2007 Trypanosoma cruzi is a kinetoplastid parasite that causes Chagas disease. Trypanosomes are unusual organisms in many aspects of its genetics and molecular and cellular biology and considered a paradigm of the exception of the rule in the eukaryotic ...
Vazquez, Martin Pablo
core
Tropical Medicine and Infectious DiseaseThis retrospective cohort study aimed to assess clinical and epidemiological characteristics, treatment outcomes, and predictors of serological cure in patients with chronic Chagas disease in a non-endemic setting.
Carlos Bea-Serrano +9 more
doaj +1 more source
Revista Peruana de Medicina Experimental y Salud PúblicaWe present a case of acute phase Chagas disease in a 40-year-old male patient from Vereda Buenos Aires, Municipality of Miraflores, Department of Guaviare. The patient attended the emergency department with fever, headache, asthenia, adynamia and dysuria.
José Ziadé Benítez +7 more
doaj +1 more source
Recent advances in the treatment of Chagas disease [PDF]
, 2013 Descoberta há cem anos, a doença de Chagas afeta a mais de quinze milhões de pessoas em toda a América Latina e, ainda hoje, não há tratamentoeficaz. O fármaco benznidazol, utilizado como única opção de tratamento no Brasil, é ineficaz na fase crônica da
da Cunha Filho, Marcílio Sérgio Soares +4 more
core +1 more source
Chagas Disease: “The Kiss of Death” [PDF]
, 2015 Chagas disease is a vector transmitted disease also known as American trypanosomiasis. Chagas disease is classified as a protist or protozoa, which is a simplified version of ‘animal-like single celled organism that is like a multicellular organism ...
Castro, Stacy, Rogers, Jessica
core +1 more source
Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease [PDF]
, 2017 Background. Nifurtimox has been used to treat Chagas disease for 40 years, but tolerance and safety data in adults are scarce. We aimed to evaluate nifurtimox tolerance and safety in a cohort of Trypanosoma cruzi-infected adult patients in a country of ...
Alirol, Emilie +5 more
core
Doença de Chagas: Contribuições do Centro de Investigações Toxicológicas [PDF]
, 2015 La quimioterapia de la enfermedad de Chagas cuenta en la actualidad con el empleo de dos fármacos solamente: Nifurtimox y Benznidazol. Nifurtimox es un nitrofurano y Benznidazol es un compuesto nitroimidazólico. El uso de estas drogas para tratar la fase
Castro, Gerardo Daniel +3 more
core
Adverse reactions to etiological treatment in patients with Chagas disease in the Western Potiguar mesoregion of Brazil: a cross-sectional study. [PDF]
Sao Paulo Med JMelo HRG +7 more
europepmc +1 more source